Last updated on August 2020

Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma


Brief description of study

The purpose of this study is to see whether the combination of avelumab and talazoparib can be an effective treatment for metastatic renal cell carcinoma.

Clinical Study Identifier: NCT04068831

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.